Prof. Shaji K. Kumar

Shaji K. Kumar, MD, is Consultant in the Division of Hematology and Professor of Medicine at Mayo Clinic Cancer Center in Rochester, Minnesota. He is the Chair of the Myeloma, Amyloidosis, and Dysproteinemia group at Mayo Clinic. He also serves as Medical Director for the Cancer Center Clinical Research Office which oversees the development, activation, conduct, and monitoring of interventional trials across the three locations of Mayo Clinic Cancer Center. Dr. Kumar is Chair and Value Pathways Task Force Member of the NCCN Multiple Myeloma/Systemic Light Chain Amyloidosis/ Waldenstrom's Macroglobulinemia Panel. He also serves as the co-chair for the NCI Myeloma Steering Committee.

Dr. Kumar received his medical degree from All India Institute of Medical Sciences in New Delhi, India. His postdoctoral training included a residency in internal medicine from the All India Institute of Medical Sciences, followed by a residency in internal medicine and a fellowship in hematology/oncology at the Mayo Graduate School of Medicine in Rochester, Minnesota. Dr. Kumar is board-certified in internal medicine with subspecialties in medical oncology and hematology.

Dr. Kumar's research focuses on the development of novel drugs for the treatment of myeloma. He is the principal investigator of clinical trials exploring new drugs and combinations for newly diagnosed and relapsed myeloma. His laboratory is focused on understanding the role of bone marrow microenvironment in the development and progression of myeloma. He has presented his research nationally and internationally and has contributed to numerous articles, abstracts, editorials, and letters in peer- reviewed publications, including Blood, Journal of Clinical Oncology, Leukemia, American Journal of Hematology, British Journal of Haematology, and Bone Marrow Transplantation.

Dr. Kumar holds membership with several professional organizations, including the American Society of Hematology, American Society of Clinical Oncology, and American Association for Cancer Research, American Society of Blood and Marrow Transplantation, the Association of Physicians of India, and the European Hematology Association. He also serves on the editorial boards for several journals, including American Journal of Hematology, European Journal of Clinical and Medical Oncology, and Leukemia.